NLM Digital Collections

Search

Start Over Subjects National Institutes of Health (U.S.) ✖Remove constraint Subjects: National Institutes of Health (U.S.) Subjects United States ✖Remove constraint Subjects: United States Dates by Range 2000 and later ✖Remove constraint Dates by Range: 2000 and later

1. As funding for BPA research increased, NIEHS followed its peer review process while also exercising its discretion

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2017
Subject(s):
Peer Review
Phenols -- adverse effects
Research -- economics
Federal Government
Financing, Government
Humans
United States
United States. Department of Health and Human Services.
National Institutes of Health (U.S.)

2. Refocusing the research enterprise in a changing health ecosystem

Publication:
Atlanta, GA : Woodruff Health Sciences Center, Emory University, 2015
Subject(s):
Academic Medical Centers -- economics
Academic Medical Centers -- organization & administration
Research -- economics
Research -- organization & administration
Electronic Health Records
Financing, Government
Interinstitutional Relations
Humans
Georgia
Michigan
Tennessee
United States
National Institutes of Health (U.S.)

3. Pediatric trauma centers: availability, outcomes, and federal support related to pediatric trauma care : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, March 2017
Subject(s):
Emergency Medical Services -- statistics & numerical data
Health Services Accessibility
Outcome Assessment (Health Care)
Pediatrics
Trauma Centers
Wounds and Injuries -- therapy
Child
Financing, Government
Hospital Mortality
Humans
United States
United States. Department of Health and Human Services.
United States. Health Resources and Services Administration.
National Institutes of Health (U.S.)

5. Drug industry: profits, research and development spending, and merger and acquisition deals : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, November 2017
Subject(s):
Drug Costs
Drug Industry -- economics
Economics, Pharmaceutical -- trends
Pharmaceutical Research -- economics
Pharmaceutical Research -- trends
Antitrust Laws
Biological Products -- economics
Drug Approval -- economics
Drug Development -- economics
Drug Development -- trends
Economic Competition
Forecasting
Orphan Drug Production -- economics
Taxes
Humans
United States
National Institutes of Health (U.S.)

6. National Institutes of Health: Better data will improve understanding of federal contributions to drug development : report to congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, April 2023
Subject(s):
Biomedical Research -- economics
Drug Development -- economics
Financing, Government -- organization & administration
Government Regulation
Health Occupations -- education
Legislation, Drug
United States
National Institutes of Health (U.S.)

8. Federal research: NIH should take further action to address foreign influence : testimony before the Committee on Health, Education, Labor and Pensions, U.S Senate

Publication:
Washington, DC : United States Government Accountability Office, April 22, 2021
Subject(s):
Biomedical Research -- legislation & jurisprudence
Conflict of Interest -- legislation & jurisprudence
Disclosure -- legislation & jurisprudence
Government Regulation
International Cooperation -- legislation & jurisprudence
United States
National Institutes of Health (U.S.)